Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
111.08
-1.32 (-1.17%)
At close: Nov 4, 2025, 4:00 PM EST
111.08
0.00 (0.00%)
After-hours: Nov 4, 2025, 4:00 PM EST
Belite Bio Market Cap
Belite Bio has a market cap or net worth of $3.92 billion as of November 4, 2025. Its market cap has increased by 128.77% in one year.
Market Cap
3.92B
Enterprise Value
3.78B
1-Year Change
128.77%
Ranking
Category
Stock Price
$111.08
Market Cap Chart
Since the IPO on April 29, 2022, Belite Bio's market cap has increased from $144.57M to $3.92B, an increase of 2,612.66%. That is a compound annual growth rate of 155.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2025 | 3.92B | 101.27% |
| Dec 31, 2024 | 1.95B | 54.32% |
| Dec 29, 2023 | 1.26B | 68.44% |
| Dec 30, 2022 | 749.63M | 418.52% |
| Apr 29, 2022 | 144.57M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.59B |
| Johnson & Johnson | 455.04B |
| AbbVie | 385.18B |
| UnitedHealth Group | 309.40B |
| AstraZeneca | 253.98B |
| Novartis AG | 237.13B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 214.96B |